/In Vitro Diagnostics
Genomic Health (oncogenomics diagnostics) netted $43.3mm through the follow-on public offering of 3mm common shares at $15.50 each. (May)
Deals Shaping the Medical Industry (6/07)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.